Impaired autophagy: The collateral damage of lysosomal storage disorders

被引:44
|
作者
Myerowitz, Rachel [1 ]
Puertollano, Rosa [2 ]
Raben, Nina [2 ]
机构
[1] St Marys Coll Maryland, Dept Biol, St Marys City, MD 20686 USA
[2] NHLBI, Cell & Dev Biol Ctr, NIH, 50 South Dr Room 3533, Bethesda, MD 20892 USA
来源
EBIOMEDICINE | 2021年 / 63卷
基金
美国国家卫生研究院;
关键词
Lysosome; Autophagy; Gaucher disease; Batten disease; Danon disease; Pompe disease; Cystinosis; ENZYME REPLACEMENT THERAPY; MOUSE MODEL; DISEASE; DEGRADATION; PROTEIN; BIOGENESIS; CYSTINOSIS; MUTATIONS; LAMP-2; TFEB;
D O I
10.1016/j.ebiom.2020.103166
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lysosomal storage disorders (LSDs), which number over fifty, are monogenically inherited and caused by mutations in genes encoding proteins that are involved in lysosomal function. Lack of the functional protein results in storage of a distinctive material within the lysosomes, which for years was thought to determine the pathophysiology of the disorder. However, our current view posits that the primary storage material disrupts the normal role of the lysosome in the autophagic pathway resulting in the secondary storage of autophagic debris. It is this "collateral damage" which is common to the LSDs but nonetheless intricately nuanced in each. We have selected five LSDs resulting from defective proteins that govern widely different lysosomal functions including glycogen degradation (Pompe), lysosomal transport (Cystinosis), lysosomal trafficking (Danon), glycolipid degradation (Gaucher) and an unidentified function (Batten) and argue that despite the disparate functions, these proteins, when mutant, all impair the autophagic process uniquely. (C) 2020 The Authors. Published by Elsevier B.V.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Treatment of lysosomal storage disorders: successes and challenges
    Hollak, Carla E. M.
    Wijburg, Frits A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2014, 37 (04) : 587 - 598
  • [22] Sphingolipid lysosomal storage disorders
    Platt, Frances M.
    NATURE, 2014, 510 (7503) : 68 - 75
  • [23] Mitochondria Dysfunction and Neurodegeneration in Lysosomal Storage Disorders
    Plotegher, Nicoletta
    Duchen, Michael R.
    TRENDS IN MOLECULAR MEDICINE, 2017, 23 (02) : 116 - 134
  • [24] Therapy for Lysosomal Storage Disorders
    Beck, Michael
    IUBMB LIFE, 2010, 62 (01) : 33 - 40
  • [25] Lysosomal Storage Disorders and Iron
    Bras, Jose Miguel
    METAL RELATED NEURODEGENERATIVE DISEASE, 2013, 110 : 251 - 275
  • [26] Lysosomal storage, impaired autophagy and innate immunity in Gaucher and Parkinson's diseases: insights for drug discovery
    Hull, Alexander
    Atilano, Magda L.
    Gergi, Laith
    Kinghorn, Kerri J.
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2024, 379 (1899)
  • [27] Protein Aggregation and Dysfunction of Autophagy-Lysosomal Pathway: A Vicious Cycle in Lysosomal Storage Diseases
    Monaco, Antonio
    Fraldi, Alessandro
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2020, 13
  • [28] Insight into the Role of Extracellular Vesicles in Lysosomal Storage Disorders
    Tancini, Brunella
    Buratta, Sandra
    Sagini, Krizia
    Costanzi, Eva
    Delo, Federica
    Urbanelli, Lorena
    Emiliani, Carla
    GENES, 2019, 10 (07):
  • [29] Pharmacological small molecules for the treatment of lysosomal storage disorders
    Smid, B. E.
    Aerts, J. M. F. G.
    Boot, R. G.
    Linthorst, G. E.
    Hollak, C. E. M.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (11) : 1367 - 1379
  • [30] Mechanisms of Mitochondrial Dysfunction in Lysosomal Storage Disorders: A Review
    Stepien, Karolina M.
    Roncaroli, Federico
    Turton, Nadia
    Hendriksz, Christian J.
    Roberts, Mark
    Heaton, Robert A.
    Hargreaves, Iain
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) : 1 - 22